Congress trades
Supernus Pharmaceuticals, Inc. (SUPN)
Free on iOS and Android.
About Supernus Pharmaceuticals, Inc.
from the company's filings and listing, as of Oct 21, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Chief executive
- Jack A. Khattar
- Employees
- 778
- Listed since
- May 1, 2012
- Market value
- $2.4B
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -$1.89
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 3, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 3, 2026 | $0.54 | $0.42 | $219.1M | $205.3M | EPS beatRevenue beat |
| Q1 FY2026reported May 5, 2026 | $0.59 | $0.28 | $207.7M | $192.9M | EPS beatRevenue beat |
| Q4 FY2025reported Feb 24, 2026 | $0.92 | $0.28 | $211.6M | $195.2M | EPS beatRevenue beat |
| Q3 FY2025reported Nov 4, 2025 | $1.01 | $0.82 | $192.1M | $194.7M | EPS beatRevenue in line |
| Q2 FY2025reported Aug 5, 2025 | $0.91 | $0.47 | $165.5M | $168.2M | EPS beatRevenue miss |
| Q1 FY2025reported May 6, 2025 | $0.42 | $0.38 | $149.8M | $147.9M | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 30, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Jack A. KhattarChief Executive Officer, President & Secretary | $1.0M | $6.5M | $7.9M | $15.5M |
| Timothy C. DecSenior Vice President, Chief Financial Officer | $505K | $315K | $1.1M | $1.9M |
| Jonathan Rubin, MDSenior Vice President, Chief Medical Officer Research and Development | $485K | $315K | $649K | $1.4M |
| Padmanabh P. Bhatt, Ph.D.Senior Vice President, Intellectual Property, Chief Scientific Officer | $456K | $315K | $620K | $1.4M |
| Frank MottolaSenior Vice President, Chief Technical Operations Officer | $413K | $315K | $633K | $1.4M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| BlackRock, Inc. | $434.9M | 9,350,046 | +6.3% | 16.10% |
| Millennium Management LLC | $179.2M | 3,853,212 | +16.2% | 6.64% |
| Vanguard Portfolio Management LLC | $153.7M | 3,305,429 | +2.1% | 5.69% |
| Armistice Capital, LLC | $123.1M | 2,646,201 | +39.6% | 4.56% |
| Vanguard Capital Management LLC | $117.1M | 2,516,721 | +2.0% | 4.33% |
| State Street Corp | $114.4M | 2,459,828 | +7.5% | 4.27% |
| Nomura Asset Management International Inc. | $110.6M | 2,378,329 | +16.7% | 4.10% |
| Dimensional Fund Advisors LP | $96.7M | 2,078,090 | -9.9% | 3.58% |
| Geode Capital Management, LLC | $73.0M | 1,570,088 | -3.3% | 2.70% |
| Stephens Investment Management Group LLC | $69.1M | 1,485,821 | +10.0% | 2.56% |
| Renaissance Technologies LLC | $68.8M | 1,478,180 | -13.3% | 2.55% |
| Loomis Sayles & Co. L.P. | $68.6M | 1,475,192 | +3.5% | 2.54% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in SUPN
9 disclosures of 9 on record · median 32d of the 45 allowedSince the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -25.4% since the tradeEstimated entry price $54.56, close on Tue Mar 3Current price $40.70, close on Fri Oct 23 | Mar 3, 2026 | Apr 7, 2026 | 35d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -12.5% since the tradeEstimated entry price $46.51, close on Thu Dec 11, 2025Current price $40.70, close on Fri Oct 23 | Dec 11, 2025 | Jan 12, 2026 | 32d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -17.8% since the saleEstimated exit price $49.51, close on Thu Oct 9, 2025Current price $40.70, close on Fri Oct 23 | Oct 9, 2025 | Nov 18, 2025 | 40d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +24.5% since the tradeEstimated entry price $32.70, close on Mon Mar 24, 2025Current price $40.70, close on Fri Oct 23 | Mar 24, 2025 | Apr 7, 2025 | 14d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/a | Dec 23, 2022 | Jan 13, 2023 | 21d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | n/a | Nov 13, 2020 | Dec 15, 2020 | 32d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | n/a | Jul 17, 2020 | Aug 19, 2020 | 33d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | n/a | Jun 1, 2020 | Jun 16, 2020 | 15d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | n/a | May 28, 2020 | Jun 10, 2020 | 13d |
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in SUPN, filterable by party, chamber, type and account.
Members of Congress reporting a position
2 members · estimate, as of Oct 20, 20262 members report a position (estimated). The largest estimated position is in the $15,001 - $50,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Josh Gottheimer | Democrat · House | $1,001 - $15,000 | <0.1% |
Estimate, as of Oct 20, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, marked to the latest close we hold. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded SUPN?
Gilbert Ray Cisneros, Jr. and Josh Gottheimer disclosed SUPN transactions in the filings shown here.
Which members of Congress hold SUPN?
2 members of Congress report a position in SUPN in the estimate we hold as of Oct 20, 2026. The estimated positions belong to Gilbert Ray Cisneros, Jr. and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are SUPN trades disclosed?
Congressional disclosures took a median of 32 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 27, 2026.